Riverview Trust Company’s Medpace MEDP Stock Holding History

Riverview Trust Company’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-101	Closed	-$17K	–	802
2022 Q1	$17K	Buy	+101	New	+$16.7K	0.01%	562

Other funds holding MEDP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return

ESCM

Echo Street Capital Management New York $747M AUM 24.25% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Riverview Trust Company's MEDP Position: Q2 2022 in Review

Riverview Trust Company sold out of Medpace (MEDP) in Q2 2022, closing a stake of 101 shares — an estimated $17K sold.

Riverview Trust Company first reported a position in MEDP in Q1 2022 and held it in 1 quarter. The position peaked at $17K in Q1 2022. 340 funds tracked by Wall St. Rank hold MEDP as of Q2 2022.

Riverview Trust Company reported no remaining Medpace position as of Q2 2022 after selling out during the quarter.
Riverview Trust Company sold 101 Medpace shares in Q2 2022, an estimated $17K.
Riverview Trust Company first reported a position in Medpace in Q1 2022 and held it in 1 quarter.
Riverview Trust Company's Medpace position peaked at $17K in Q1 2022.
340 funds tracked by Wall St. Rank held Medpace as of Q2 2022.

Based on Riverview Trust Company's 13F filing for Q2 2022, filed 27 Jul 2022.